CYABRA, INC. director Michael P. Madon received a fully vested stock option grant tied to the company’s recent business combination. The award covers options to buy 14,436 shares of common stock at an exercise price of $1.00 per share, expiring on January 8, 2035.
According to the footnotes, this option replaces a prior Cyabra Strategy Ltd. option for 4,000 ordinary shares under the merger agreement with Trailblazer Merger Corporation I. After this grant, Madon holds options covering 14,436 shares, reflecting compensation and equity alignment following the transaction.
This Form 3 identifies Dan Brahmy, Chief Executive Officer and director of Cyabra, Inc., as a reporting person and insider of the company. The provided data shows no reported share transactions or derivative positions, functioning as an initial status disclosure rather than a trading report.
CYABRA, INC. director and Chief Product Officer Yossef Daar has filed an initial statement of beneficial ownership on Form 3. This filing identifies him as both a director and officer of CYABRA, INC. but does not report any specific share transactions or detailed holdings in the provided data.
CYABRA, INC. director Michael Pompeo filed an initial Form 3 as a reporting person for the company. The filing lists him as a director and indicates no reportable transactions or derivative positions at this time, establishing his insider status under SEC rules.
Alpha Capital Anstalt reports beneficial ownership of 1,380,031 shares of Cyabra, Inc. common stock, equal to 9.99% of the class. The filing cites 13,814,125 shares outstanding as of March 27, 2026 and notes a contractually stipulated 9.99% ownership restriction that limits Alpha Capital Anstalt's maximum controllable shares.
Cyabra, Inc. registered up to 14,042,892 shares of Common Stock for resale by selling shareholders in connection with its business combination. The shares were issued related to the merger with Trailblazer and related transactions, and the registration permits those holders to sell their shares from time to time.
The company will not receive proceeds from resale transactions, although it may receive up to $4,600,000 if the 400,000 PIPE Warrants are exercised for cash at $11.50 per share. Shares outstanding after the Business Combination were reported as 13,814,125 shares (assuming no PIPE cash exercise and no earnout issuance).